Wells Fargo & Company Allakos Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Allakos Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 100 shares of ALLK stock, worth $28. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 600 83.33%
Holding current value
$28
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$0.62 - $1.5 $310 - $750
-500 Reduced 83.33%
100 $0
Q2 2024

Aug 13, 2024
SELL
$1.0 - $1.45 $23,741 - $34,424
-23,741 Reduced 97.54%
600 $0
Q1 2024

May 10, 2024
BUY
$1.02 - $3.23 $3,326 - $10,533
3,261 Added 15.47%
24,341 $30,000
Q4 2023

Feb 09, 2024
BUY
$1.72 - $3.18 $6,955 - $12,859
4,044 Added 23.74%
21,080 $57,000
Q3 2023

Nov 13, 2023
SELL
$2.13 - $5.55 $146,009 - $380,446
-68,549 Reduced 80.09%
17,036 $38,000
Q2 2023

Aug 15, 2023
BUY
$3.6 - $5.25 $77,529 - $113,064
21,536 Added 33.62%
85,585 $373,000
Q1 2023

May 12, 2023
BUY
$4.3 - $8.27 $267,692 - $514,840
62,254 Added 3468.19%
64,049 $285,000
Q4 2022

Feb 13, 2023
SELL
$5.66 - $8.42 $3,877 - $5,767
-685 Reduced 27.62%
1,795 $15,000
Q3 2022

Nov 14, 2022
BUY
$3.02 - $6.12 $2,579 - $5,226
854 Added 52.52%
2,480 $15,000
Q2 2022

Aug 12, 2022
SELL
$2.6 - $6.14 $23,795 - $56,193
-9,152 Reduced 84.91%
1,626 $5,000
Q1 2022

May 16, 2022
SELL
$5.08 - $9.81 $64,043 - $123,674
-12,607 Reduced 53.91%
10,778 $62,000
Q4 2021

Feb 14, 2022
BUY
$8.55 - $111.89 $60,439 - $790,950
7,069 Added 43.33%
23,385 $229,000
Q3 2021

Nov 15, 2021
BUY
$76.53 - $110.43 $632,750 - $913,035
8,268 Added 102.73%
16,316 $1.73 Million
Q2 2021

Aug 16, 2021
BUY
$85.37 - $114.1 $260,122 - $347,662
3,047 Added 60.93%
8,048 $686,000
Q1 2021

May 13, 2021
SELL
$109.73 - $153.66 $1.52 Million - $2.13 Million
-13,881 Reduced 73.51%
5,001 $574,000
Q4 2020

Feb 09, 2021
BUY
$79.58 - $152.45 $399,412 - $765,146
5,019 Added 36.2%
18,882 $2.64 Million
Q3 2020

Nov 05, 2020
BUY
$66.43 - $90.99 $38,064 - $52,137
573 Added 4.31%
13,863 $1.13 Million
Q2 2020

Aug 13, 2020
BUY
$44.04 - $80.69 $74,956 - $137,334
1,702 Added 14.69%
13,290 $955,000
Q1 2020

May 14, 2020
BUY
$44.49 - $93.39 $515,550 - $1.08 Million
11,588 New
11,588 $515,000

Others Institutions Holding ALLK

# of Institutions
79
Shares Held
68.8M
Call Options Held
20.9K
Put Options Held
0
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $23.7M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email